SecBot SecBot
PRESS-RELEASE ·Filed Apr 3, 2026

ORIC

ORIC Pharmaceuticals
NEUTRAL
Impact 2/10
Horizonmonths Processed7mo ago WireGlobeNewswire
Press release · Regulatory
Actionable Insight • Neutral

This is a standard inducement grant for a new hire and should not be interpreted as a strategic or financial signal. Traders should monitor upcoming clinical trial updates for ORIC-944 and enozertinib as the primary value drivers.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$8.91
T+0 close · Apr 3, 2026 · via day close
Latest settled
+22.22%
T+60 · $10.89
Vs SPY
+8.75%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 6 $8.91entry
  2. T+1 · 7mo ago −0.45%α −0.51% · $8.87
  3. T+5 · 7mo ago +16.72%α +12.59% · $10.40
  4. T+20 · 7mo ago +8.08%α −0.90% · $9.63
  5. T+60 · 5mo ago +22.22%α +8.75% · $10.89
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

ORIC Pharmaceuticals announced the grant of stock options and restricted stock units to a new non-executive employee as an inducement to employment, approved under Nasdaq Rule 5635(c)(4). The move is a routine hiring incentive and does not reflect a material change in the company's operations or financial condition.

Key Facts

  • ORIC granted 80,000 non-qualified stock options and 15,000 restricted stock units to a new non-executive employee.
  • Grants were made on April 1, 2026, under the 2022 Inducement Equity Incentive Plan.
  • Stock options vest 25% after one year, with the remainder vesting monthly over 36 months; RSUs vest in thirds over three years.
  • The Compensation Committee approved the grants in accordance with Nasdaq rules for inducement awards.

Financial Impact

Minimal near-term financial impact; total equity grant of 95,000 shares represents less than 0.1% of outstanding shares (based on $892M market cap).

dilutionshare_count

Risk Factors

  • Potential for minor shareholder dilution over time as equity vests.
  • Forward-looking statements in the release carry standard biotech development risks, including clinical trial failure and funding needs.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3268139

Track record

12 reports on ORIC

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 16, 2026today Press Release Neutral 5/10 Entry $7.52 Now $7.52 −0.00% settles Nov 24
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $7.59 Now $7.52 −0.92% settles Nov 23
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $7.72 Now $7.52 −2.59% settles Nov 23
  4. Nov 9, 20267d ago Institutional Cluster Mixed 3/10 Entry $8.91 Now $7.52 −15.60% settles Nov 17
  5. Oct 23, 202624d ago 8-K Bullish 7/10 Entry $13.17 to $9.24 Now $7.52 −42.90% ▼ −29.84% −29.28% vs SPY
  6. Oct 5, 20266w ago Press Release Bullish 6/10 Entry $11.98 to $11.31 Now $7.52 −37.23% ▼ −5.59% −5.45% vs SPY
  7. Oct 2, 20266w ago Insider Cluster Neutral 3/10 Entry $12.49 to $11.81 Now $7.52 −39.79% ▼ −5.44% −5.87% vs SPY
  8. Aug 3, 202615w ago Press Release Neutral 5/10 Entry $13.47 to $13.73 Now $7.52 −44.17% ▲ +1.93% +2.03% vs SPY
  9. Jun 22, 202621w ago 8-K Neutral 3/10 Entry $8.91 to $10.16 Now $7.52 −15.60% ▲ +13.97% +12.96% vs SPY
  10. Jun 11, 202622w ago Institutional Cluster Neutral 3/10 Entry $7.82 to $8.63 Now $7.52 −3.84% ▲ +10.36% +9.92% vs SPY
Showing 10 of 12

US Market Status

Market Closed · Opens in 6h 42m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 3, 2026